AbCellera Biologics Inc.ABCLNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-27.4%
5Y CAGR-41.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-27.4%/yr
vs -76.5%/yr prior
5Y CAGR
-41.4%/yr
Recent acceleration
Acceleration
+49.1pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.90 | +9.6% |
| 2024 | 0.82 | -43.0% |
| 2023 | 1.43 | -38.8% |
| 2022 | 2.34 | -39.1% |
| 2021 | 3.84 | -70.4% |
| 2020 | 12.98 | -99.0% |
| 2019 | 1237.61 | +61.5% |
| 2018 | 766.43 | - |